Elijah E. Cummings Lower Drug Costs Now Act
Referred to the Subcommittee on Oversight and Investigations.
Sign in to view Hilltelligence’s plain-English summary.
- HouseLatest
Referred to the Subcommittee on Oversight and Investigations.
- House
Referred to the Subcommittee on Health.
- House
Referred to the Subcommittee on Health.
- House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, Oversight and Reform, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- House
Introduced in House
Sign in to view Hilltelligence’s passage-probability analysis.
- Medicare Drug Price Negotiation Under the Inflation Reduction Act: Industry Responses and Potential Effects
R47872 · Dec 8, 2023
- Advanced Research Projects Agency for Health (ARPA-H): Considerations for Congress
IN11674 · May 18, 2021
- Frequently Asked Questions About Prescription Drug Pricing and Policy
R44832 · May 6, 2021
Nonpartisan Congressional Research Service products citing this bill.
Policy area
Sign in to view Hilltelligence’s potential-cosponsor analysis.